Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
COVID-19 Related Coagulopathy: A Distinct Entity?
Benjamin Marchandot1, Laurent Sattler2, Laurence Jesel1,3
1Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, 67000 Strasbourg, France.
The COVID-19 pandemic caused severe health issues, particularly with blood clotting problems (coagulopathy). This review covers the causes, symptoms, and treatments for COVID-19-related coagulopathy.
Area of Science:
- Infectious Diseases
- Hematology
- Public Health
Background:
- The COVID-19 pandemic has caused widespread global health challenges.
- COVID-19 patients exhibit varied clinical outcomes.
- Coagulopathy is a significant complication associated with severe COVID-19 outcomes.
Purpose of the Study:
- To review the current evidence on COVID-19-related coagulopathy.
- To summarize the epidemiology, clinical features, and pathophysiology of COVID-19 coagulopathy.
- To outline current treatment guidance for COVID-19 coagulopathy.
Main Methods:
- This study is a narrative review.
- It synthesizes existing scientific literature and clinical evidence.
- Focuses on research related to COVID-19 and coagulopathy.
Main Results:
- COVID-19 coagulopathy is linked to significantly worse patient outcomes.
- Evidence covers the occurrence, presentation, and underlying mechanisms of COVID-19-induced blood clotting issues.
- Current treatment strategies are discussed.
Conclusions:
- Understanding COVID-19 coagulopathy is crucial for managing severe cases.
- Further research into pathophysiology and treatment is warranted.
- Effective management of coagulopathy can improve patient prognosis in COVID-19.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins